Delhi Covid-19 vaccine stock to last for less than a day: Bulletin

Delhi had less than a day's stock of coronavirus vaccine doses left on Sunday morning, according to the vaccination bulletin issued by the city government

Covishield
Photo: Shutterstock
Press Trust of India New Delhi
2 min read Last Updated : Jul 18 2021 | 7:54 PM IST

Delhi had less than a day's stock of coronavirus vaccine doses left on Sunday morning, according to the vaccination bulletin issued by the city government.

The national capital received 60,000 doses of Covishield on Saturday, taking the total number of doses to 72,240, the bulletin said.

The number of Covaxin doses available in the national capital stands at 2,05,630. Only 20 per cent of Covaxin doses are to be used for first dose, since its stocks are limited and have irregular delivery cycles.

As many as 93,55,271 vaccine doses have been administered in the national capital till date, including 22,15,357 second doses, according to data on the CoWIN portal.

Over 45.31 lakh people in the 18-44 age group have been administered Covid vaccine in the national capital till date and over 29.89 lakh have been inoculated in the 45-60 age group. Among those aged above 60, more than 18.34 lakh people have received at least one vaccine dose.

As many as 53,86,412 males have been inoculated while 39,66,823 females have received at least one dose of the vaccine.

The government vaccination centres are shut on Sunday.

Only 10,767 vaccine doses were administered on Sunday at 75 centres, including one government centre and rest were at private centres, according to the portal.

A total of 71,786 vaccine doses were administered on Saturday, including 23,449 second doses, the bulletin stated.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineDelhiVaccination

First Published: Jul 18 2021 | 7:54 PM IST

Next Story